Weiss Multi Strategy Advisers LLC Exelixis, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

$0
Q1 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$19.25 - $24.13 $676,637 - $848,169	-35,150 Reduced 63.91%	19,850 $476,000
Q3 2023 Nov 14, 2023	SELL	$19.04 - $22.74 $2.93 Million - $3.49 Million	-153,635 Reduced 73.64%	55,000 $1.2 Million
Q2 2023 Aug 14, 2023	SELL	$18.17 - $20.48 $3.35 Million - $3.77 Million	-184,127 Reduced 46.88%	208,635 $3.99 Million
Q1 2023 May 15, 2023	BUY	$16.3 - $19.41 $3.47 Million - $4.13 Million	212,762 Added 118.2%	392,762 $7.62 Million
Q4 2022 Feb 14, 2023	SELL	$14.96 - $17.39 $1.24 Million - $1.44 Million	-82,663 Reduced 31.47%	180,000 $2.89 Million
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $2.4 Million - $3.4 Million	152,753 Added 138.98%	262,663 $4.12 Million
Q2 2022 Aug 15, 2022	BUY	$17.44 - $23.16 $295,154 - $391,959	16,924 Added 18.2%	109,910 $2.29 Million
Q1 2022 May 16, 2022	SELL	$17.03 - $22.67 $27,963 - $37,224	-1,642 Reduced 1.74%	92,986 $2.11 Million
Q4 2021 Feb 14, 2022	SELL	$15.84 - $21.88 $5,892 - $8,139	-372 Reduced 0.39%	94,628 $1.73 Million
Q3 2021 Nov 15, 2021	BUY	$16.3 - $21.14 $163,000 - $211,400	10,000 Added 11.76%	95,000 $2.01 Million
Q2 2021 Aug 16, 2021	BUY	$17.95 - $25.56 $166,576 - $237,196	9,280 Added 12.26%	85,000 $1.55 Million
Q1 2021 May 14, 2021	SELL	$20.53 - $25.22 $191,360 - $235,075	-9,321 Reduced 10.96%	75,720 $1.71 Million
Q4 2020 Feb 16, 2021	SELL	$18.39 - $24.8 $275,096 - $370,983	-14,959 Reduced 14.96%	85,041 $1.71 Million
Q3 2020 Nov 16, 2020	SELL	$20.67 - $26.94 $116,248 - $151,510	-5,624 Reduced 5.32%	100,000 $2.45 Million
Q2 2020 Aug 14, 2020	SELL	$16.46 - $27.42 $44,524 - $74,171	-2,705 Reduced 2.5%	105,624 $2.51 Million
Q1 2020 May 15, 2020	BUY	$14.46 - $21.8 $120,437 - $181,572	8,329 Added 8.33%	108,329 $1.87 Million
Q4 2019 Feb 14, 2020	SELL	$15.15 - $18.89 $151,500 - $188,900	-10,000 Reduced 9.09%	100,000 $1.76 Million
Q3 2019 Nov 14, 2019	BUY	$17.68 - $22.65 $176,800 - $226,500	10,000 Added 10.0%	110,000 $1.95 Million
Q4 2018 Feb 14, 2019	SELL	$13.65 - $21.8 $341,250 - $545,000	-25,000 Reduced 20.0%	100,000 $1.97 Million
Q3 2018 Nov 14, 2018	SELL	$15.87 - $22.4 $15,854 - $22,377	-999 Reduced 0.79%	125,000 $2.22 Million
Q2 2018 Aug 14, 2018	BUY	$18.56 - $22.45 $482,541 - $583,677	25,999 Added 26.0%	125,999 $2.71 Million
Q1 2018 May 15, 2018	BUY	$22.15 - $31.89 $775,250 - $1.12 Million	35,000 Added 53.85%	100,000 $2.22 Million
Q4 2017 Feb 14, 2018	BUY	$24.23 - $30.93 $363,450 - $463,950	15,000 Added 30.0%	65,000 $1.98 Million
Q3 2017 Nov 14, 2017	BUY	$23.35 - $29.24 $1.17 Million - $1.46 Million	50,000	50,000 $1.21 Million

Others Institutions Holding EXEL

# of Institutions

503

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.2 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$1.05 Billion
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$913 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$552 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$411 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.

Account